| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4005022 | American Journal of Ophthalmology | 2007 | 9 Pages |
Abstract
Intravitreal bevacizumab seems to be a promising therapeutic option in eyes with neovascular AMD and large submacular hemorrhages, with a stabilization in VA and anatomic improvement.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Eva Stifter, Stephan Michels, Franz Prager, Michael Georgopoulos, Kaija Polak, Cornelia Hirn, Ursula Schmidt-Erfurth,